Loading data
GENCNYSE
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Cost of revenue | 83.72 m USD | 81.84 m USD | 76.04 m USD | 82.94 m USD |
| Gross profit | 31.71 m USD | 31.33 m USD | 29.04 m USD | 20.54 m USD |
| Research and development expense | 2.76 m USD | 3.31 m USD | 3.46 m USD | 4.33 m USD |
| Selling, general and administrative expense | 14.94 m USD | 14.33 m USD | 12.15 m USD | 12.05 m USD |
| Operating profit | 14.02 m USD | 13.69 m USD | 13.43 m USD | 4.17 m USD |
| Profit before tax | 20.2 m USD | 20.73 m USD | 18.78 m USD | -1.69 m USD |
| Income tax expense | 4.54 m USD | 6.17 m USD | 4.11 m USD | -1.32 m USD |
| Net income (reported basis) | 15.66 m USD | 14.56 m USD | 14.67 m USD | -372 k USD |
| Basic earnings per share | 1.07 USD/share | 0.99 USD/share | 1 USD/share | -0.03 USD/share |
| Diluted earnings per share | 1.07 USD/share | 0.99 USD/share | 1 USD/share | -0.03 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.